Optimal use of meningococcal serogroup B vaccines: moving beyond outbreak control
Neisseria meningitidis is a major cause of meningitis and septicemia globally. Vaccines directed against N. meningitidis serogroup B (MenB) have been used to control sporadic and sustained disease in industrialized and non-industrialized countries. Early outer membrane vesicle (OMV) vaccines effecti...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
SAGE Publishing,
2018-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|